martes, 28 de junio de 2016

Clinical Proteomics | Celebrating Clinical Proteomic’s first Impact Factor

Clinical Proteomics | Home page

Biomed Central logo

Impact Factor: 3.476
Editor-in-Chief: Daniel W Chan

We are very pleased to announce that the open access journal Clinical Proteomics has received its first Impact Factor of 3.476.
As you know, the Impact Factor is just one measure used for evaluating a journal. Should you be interested in more information on the Impact Factor in general and alternative metrics, please click here.
Read these influential articles and submit your next manuscript to the journal.

Journal Scope
Clinical Proteomics encompasses all aspects of translational proteomics. Special emphasis will be placed on the application of proteomic technology to all aspects of clinical research and molecular medicine. The journal is committed to rapid scientific review and timely publication of submitted manuscripts.

The Benefits of Publishing with Us
Rapid, stringent peer-review - most first editorial decisions are made within 40 days
Provides a unique venue for international reviews and perspectives
Publishes research across the broad spectrum of clinical and translational proteomics

Please forward this email and share the good news.

Best wishes,

The BioMed Central Team
For further information or enquiries please contact Customer Services
BioMed Central Ltd 
236 Gray's Inn Road, London, WC1X 8HB, 
United Kingdom.

Editor's profile

Dr Daniel W Chan  is currently Professor of Pathology, Oncology, Urology, and Radiology at Johns Hopkins Medical Institutions, and Director of the Clinical Chemistry Division, Co-Director at the Pathology Core Laboratory, and Director at the Center for Biomarker Discovery and Translation at the Johns Hopkins University School of Medicine. He has worked extensively on the development and application of proteomic and immunologic techniques in the understanding of cancer. As the author of five books and over 300 articles, Dr Chan has become established as a leading expert in clinical proteomics and cancer research. Dr Chan is an active member of US Human Proteome Organization (USHUPO), American Association for Cancer Research (AACR) and American Association for Clinical Chemistry (AACC).


    Phosphotyrosine profiling of curcumin-induced signaling

    Gajanan Sathe, Sneha M. Pinto, Nazia Syed, Vishalakshi Nanjappa, Hitendra S. Solanki, Santosh Renuse, Sandip Chavan, Aafaque Ahmad Khan, Arun H. Patil, Raja Sekhar Nirujogi, Bipin Nair, Premendu Prakash Mathur, T. S. Keshava Prasad, Harsha Gowda and Aditi Chatterjee
    Published on: 15 June 2016

    Synovial fluid proteome in rheumatoid arthritis

    Mitali Bhattacharjee, Lavanya Balakrishnan, Santosh Renuse, Jayshree Advani, Renu Goel, Gajanan Sathe, T. S. Keshava Prasad, Bipin Nair, Ramesh Jois, Subramanian Shankar and Akhilesh Pandey
    Published on: 5 June 2016

No hay comentarios:

Publicar un comentario